A review of oral labetalol and nifedipine in mild to moderate hypertension in pregnancy

Shannon Clark, Holly E. Dunn, Gary Hankins

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Hypertension is the most commonly encountered medical condition in pregnancy, contributing significantly to maternal and perinatal morbidity and mortality. Mild to moderate hypertension in pregnancy is defined as systolic blood pressure of 140-159 mmHg or diastolic blood pressure of 90-109 mmHg (7-9% of pregnancies). When treating hypertension in pregnancy, not only do physiologic changes of pregnancy have an effect on the pharmacokinetics and pharmacodynamics of the drugs used, but the pathophysiology of hypertensive disorders of pregnancy also have an effect. To date, evidence is lacking on the pharmacokinetics and pharmacodynamics of commonly used antihypertensive drugs, which oftentimes leads to suboptimal treatment of hypertensive pregnant women. When considering which agents to use for treatment of mild to moderate hypertension, specifically in gestational and chronic hypertension, oral labetalol and nifedipine are valid options. An overview of the profile for use, safety, and current pharmacokinetic data for each agent is presented here.

Original languageEnglish (US)
Pages (from-to)548-555
Number of pages8
JournalSeminars in Perinatology
Volume39
Issue number7
DOIs
StatePublished - Nov 1 2015

Fingerprint

Labetalol
Nifedipine
Hypertension
Pregnancy
Blood Pressure
Pharmacokinetics
Pregnancy Induced Hypertension
Perinatal Mortality
Antihypertensive Agents
Pregnant Women
Mothers
Morbidity
Safety
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Cite this

A review of oral labetalol and nifedipine in mild to moderate hypertension in pregnancy. / Clark, Shannon; Dunn, Holly E.; Hankins, Gary.

In: Seminars in Perinatology, Vol. 39, No. 7, 01.11.2015, p. 548-555.

Research output: Contribution to journalArticle

@article{0e193bd7f9184fa8bab1f08ef7abea79,
title = "A review of oral labetalol and nifedipine in mild to moderate hypertension in pregnancy",
abstract = "Hypertension is the most commonly encountered medical condition in pregnancy, contributing significantly to maternal and perinatal morbidity and mortality. Mild to moderate hypertension in pregnancy is defined as systolic blood pressure of 140-159 mmHg or diastolic blood pressure of 90-109 mmHg (7-9{\%} of pregnancies). When treating hypertension in pregnancy, not only do physiologic changes of pregnancy have an effect on the pharmacokinetics and pharmacodynamics of the drugs used, but the pathophysiology of hypertensive disorders of pregnancy also have an effect. To date, evidence is lacking on the pharmacokinetics and pharmacodynamics of commonly used antihypertensive drugs, which oftentimes leads to suboptimal treatment of hypertensive pregnant women. When considering which agents to use for treatment of mild to moderate hypertension, specifically in gestational and chronic hypertension, oral labetalol and nifedipine are valid options. An overview of the profile for use, safety, and current pharmacokinetic data for each agent is presented here.",
author = "Shannon Clark and Dunn, {Holly E.} and Gary Hankins",
year = "2015",
month = "11",
day = "1",
doi = "10.1053/j.semperi.2015.08.011",
language = "English (US)",
volume = "39",
pages = "548--555",
journal = "Seminars in Perinatology",
issn = "0146-0005",
publisher = "W.B. Saunders Ltd",
number = "7",

}

TY - JOUR

T1 - A review of oral labetalol and nifedipine in mild to moderate hypertension in pregnancy

AU - Clark, Shannon

AU - Dunn, Holly E.

AU - Hankins, Gary

PY - 2015/11/1

Y1 - 2015/11/1

N2 - Hypertension is the most commonly encountered medical condition in pregnancy, contributing significantly to maternal and perinatal morbidity and mortality. Mild to moderate hypertension in pregnancy is defined as systolic blood pressure of 140-159 mmHg or diastolic blood pressure of 90-109 mmHg (7-9% of pregnancies). When treating hypertension in pregnancy, not only do physiologic changes of pregnancy have an effect on the pharmacokinetics and pharmacodynamics of the drugs used, but the pathophysiology of hypertensive disorders of pregnancy also have an effect. To date, evidence is lacking on the pharmacokinetics and pharmacodynamics of commonly used antihypertensive drugs, which oftentimes leads to suboptimal treatment of hypertensive pregnant women. When considering which agents to use for treatment of mild to moderate hypertension, specifically in gestational and chronic hypertension, oral labetalol and nifedipine are valid options. An overview of the profile for use, safety, and current pharmacokinetic data for each agent is presented here.

AB - Hypertension is the most commonly encountered medical condition in pregnancy, contributing significantly to maternal and perinatal morbidity and mortality. Mild to moderate hypertension in pregnancy is defined as systolic blood pressure of 140-159 mmHg or diastolic blood pressure of 90-109 mmHg (7-9% of pregnancies). When treating hypertension in pregnancy, not only do physiologic changes of pregnancy have an effect on the pharmacokinetics and pharmacodynamics of the drugs used, but the pathophysiology of hypertensive disorders of pregnancy also have an effect. To date, evidence is lacking on the pharmacokinetics and pharmacodynamics of commonly used antihypertensive drugs, which oftentimes leads to suboptimal treatment of hypertensive pregnant women. When considering which agents to use for treatment of mild to moderate hypertension, specifically in gestational and chronic hypertension, oral labetalol and nifedipine are valid options. An overview of the profile for use, safety, and current pharmacokinetic data for each agent is presented here.

UR - http://www.scopus.com/inward/record.url?scp=84945493590&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945493590&partnerID=8YFLogxK

U2 - 10.1053/j.semperi.2015.08.011

DO - 10.1053/j.semperi.2015.08.011

M3 - Article

VL - 39

SP - 548

EP - 555

JO - Seminars in Perinatology

JF - Seminars in Perinatology

SN - 0146-0005

IS - 7

ER -